[{"Assets_0_Q2_USD":9833000.0,"CommonStockSharesOutstanding_0_Q2_shares":6895509.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-2769000.0,"NetIncomeLoss_2_Q2_USD":-4613000.0,"NetIncomeLoss_1_Q2_USD":-2452000.0,"StockholdersEquity_0_Q2_USD":8546000.0,"Ticker":"SAVA","CIK":"1069530","name":"PAIN THERAPEUTICS INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180726"}]